Pazopanib hydrochloride
98%
- Product Code: 53310
CAS:
635702-64-6
| Molecular Weight: | 473.99 g./mol | Molecular Formula: | C₂₁H₂₃N₇O₂SHCl |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | 728.8ºC at 760 mmHg | |
| Density: | Storage Condition: | 2~8 ℃ |
Product Description:
Pazopanib hydrochloride is primarily used in the treatment of advanced renal cell carcinoma (kidney cancer) and soft tissue sarcoma. It works by inhibiting multiple tyrosine kinases, which are involved in tumor growth and angiogenesis. This helps to slow down or stop the progression of cancer by blocking the blood supply to tumors.
In clinical practice, it is administered orally, offering a convenient treatment option for patients. It is often prescribed when other treatments have not been effective or are unsuitable. Patients undergoing this therapy are closely monitored for side effects, such as hypertension, liver dysfunction, and fatigue, to ensure safe and effective use.
Additionally, pazopanib hydrochloride has shown potential in research for treating other types of cancers, though these applications are still under investigation. Its targeted mechanism of action makes it a valuable option in personalized cancer therapy.
Product Specification:
| Test | Specification |
|---|---|
| APPEARANCE | White to off-white or yellow solid |
| PURITY | 97.5 |
| CARBON BY ELEMENTAL ANALYSIS | 51.6 % 53.6 % |
| NITROGEN BY ELEMENTAL ANALYSIS | 19.8 % 21.2 % |
| PROTON NMR SPECTRUM | Conforms to Structure |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.250 | 10-20 days | ฿1,200.00 |
+
-
|
| 1.000 | 10-20 days | ฿3,600.00 |
+
-
|
Pazopanib hydrochloride
Pazopanib hydrochloride is primarily used in the treatment of advanced renal cell carcinoma (kidney cancer) and soft tissue sarcoma. It works by inhibiting multiple tyrosine kinases, which are involved in tumor growth and angiogenesis. This helps to slow down or stop the progression of cancer by blocking the blood supply to tumors.
In clinical practice, it is administered orally, offering a convenient treatment option for patients. It is often prescribed when other treatments have not been effective or are unsuitable. Patients undergoing this therapy are closely monitored for side effects, such as hypertension, liver dysfunction, and fatigue, to ensure safe and effective use.
Additionally, pazopanib hydrochloride has shown potential in research for treating other types of cancers, though these applications are still under investigation. Its targeted mechanism of action makes it a valuable option in personalized cancer therapy.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :